Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47410
Title: International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, Adult and Pediatric Units, Device-associated Module
Authors: Daniel Rosenthal, Victor
Duszynska, Wieslawa
Ider, Bat-Erdene
Gurskis, Vaidotas
Al-Ruzzieh, Majeda A.
Myatra, Sheila Nainan
Gupta, Debkishore
Belkebir, Souad
Upadhyay, Namita
Zand, Farid
Todi, Subhash Kumar
Kharbanda, Mohit
Nair, Pravin K.
Mishra, Sanghamitra
Chaparro, Gustavo
Mehta, Yatin
Zala, Dolatsinh
Janc, Jaroslaw
Aguirre-Avalos, Guadalupe
Aguilar-De-Moros, Daisy
Estela Hernandez-Chena, Blanca
Gün, Emrah
Öztoprak Çuvalcı, Nefise
Yıldızdaş, Dinçer
Abdelhalim, Mona Moheyeldin
Özturk Deniz, Suna Seçil
Gan, Chin Seng
Nguyen Viet Hung
Joudi, Hala
Omar, Abeer Aly
Gikas, Achilleas
El-Kholy, Amani Ali
Barkat, Amina
Koirala, Anjeela
Cerero-Gudino, Antonio
Bouziri, Asma
Gomez-Nieto, Katherine
Fisher, Dale
Medeiros, Eduardo A.
Salgado-Yepez, Estuardo
Horhat, Florin
Agha, Hala Mounir Moustafa
Cesar Vimercati, Julio
Villanueva, Victoria
Jayatilleke, Kushlani
Le Thi Thu Nguyet
Raka, Lul
Guadalupe Miranda-Novales, Maria
Petrov, Michael Mihailov
Apisarnthanarak, Anucha
Tayyab, Nadia
Elahi, Naheed
Mejia, Nepomuceno
Morfin-Otero, Rayo
Al-Khawaja, Safa
Anguseva, Tanja
Gupta, Umesh
Belskii, Vladislav A.
Mat, Wan Rahiza Wan
Giovanny Chapeta-Parada, Edwin
Guanche-Garcell, Humberto
Pattnaik, Saroj Kumar
Pandya, Nirav
Poojary, Aruna Ananda
Chawla, Rajesh
Mahfouz, Tahsine
Kanj, Souha S.
Mioljevic, Vesna
Hlinkova, Sona
Mrazova, Mariana
Al-Abdely, Hail M.
Güçlü, Ertuğrul
Özgültekin, Asu
Baytaş, Volkan
Tekin, Recep
Yalçın, Ata Nevzat
Erben, Nurettin
Keywords: Bacterial resistance
Device-associated infection
Health care-associated infection
Hospital infection
Limited resources countries
Nosocomial infection
amikacin
ceftazidime
ciprofloxacin
colistin
imipenem
oxacillin
vancomycin
adult
antibiotic resistance
Article
catheter infection
child
cohort analysis
device infection
disease surveillance
Enterococcus
healthcare associated infection
hospital infection
human
infection control
intensive care unit
Klebsiella
length of stay
major clinical study
medical device complication
nonhuman
pediatric intensive care unit
prospective study
Pseudomonas aeruginosa
Staphylococcus
Staphylococcus aureus
treatment duration
urinary tract infection
ventilator associated event
bacterial infection
catheter infection
cross infection
intensive care unit
urinary tract infection
ventilator associated pneumonia
Adult
Bacterial Infections
Catheter-Related Infections
Child
Cross Infection
Humans
Infection Control
Intensive Care Units
Pneumonia, Ventilator-Associated
Prospective Studies
Urinary Tract Infections
Publisher: Mosby Inc.
Abstract: Background: We report the results of INICC surveillance study from 2013 to 2018, in 664 intensive care units (ICUs) in 133 cities, of 45 countries, from Latin-America, Europe, Africa, Eastern-Mediterranean, Southeast-Asia, and Western-Pacific. Methods: Prospective data from patients hospitalized in ICUs were collected through INICC Surveillance Online System. CDC-NHSN definitions for device-associated healthcare-associated infection (DA-HAI) were applied. Results: We collected data from 428,847 patients, for an aggregate of 2,815,402 bed-days, 1,468,216 central line (CL)-days, 1,053,330 mechanical ventilator (MV)-days, 1,740,776 urinary catheter (UC)-days. We found 7,785 CL-associated bloodstream infections (CLAB), 12,085 ventilator-associated events (VAE), and 5,509 UC-associated urinary tract infections (CAUTI). Pooled DA-HAI rates were 5.91% and 9.01 DA-HAIs/1,000 bed-days. Pooled CLAB rate was 5.30/1,000 CL-days; VAE rate was 11.47/1,000 MV-days, and CAUTI rate was 3.16/1,000 UC-days. P aeruginosa was non-susceptible (NS) to imipenem in 52.72% of cases; to colistin in 10.38%; to ceftazidime in 50%; to ciprofloxacin in 40.28%; and to amikacin in 34.05%. Klebsiella spp was NS to imipenem in 49.16%; to ceftazidime in 78.01%; to ciprofloxacin in 66.26%; and to amikacin in 42.45%. coagulase-negative Staphylococci and S aureus were NS to oxacillin in 91.44% and 56.03%, respectively. Enterococcus spp was NS to vancomycin in 42.31% of the cases. Conclusions: DA-HAI rates and bacterial resistance are high and continuous efforts are needed to reduce them. © 2021
URI: https://doi.org/10.1016/j.ajic.2021.04.077
https://hdl.handle.net/11499/47410
ISSN: 0196-6553
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Show full item record



CORE Recommender

SCOPUSTM   
Citations

62
checked on Oct 13, 2024

Page view(s)

58
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.